FindTrial
Sign In

The role of blood eosinophils in the prognosis assessment of acute exacerbations of chronic obstructive pulmonary disease-a real-world study

The role of blood eosinophils in the prognosis assessment of acute exacerbations of chronic obstructive pulmonary disease-a real-world study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052783
Enrollment
Unknown
Registered
2021-11-05
Start date
2013-01-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

None listed

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inpatients with AECOPD: 1. Aged >= 40 years; 2. The diagnosis is confirmed by medical history, physical examination, chest X-ray or high-resolution chest CT, and lung function (FEV1/FVC<70%, and FEV1 accounts for the predicted value% < 80%). The diagnosis complies with the COPD diagnosis and treatment guidelines formulated by the Respiratory Medicine Branch of the Chinese Medical Association.

Exclusion criteria

Exclusion criteria: Disagree to join the study.

Design outcomes

Primary

MeasureTime frame
death;Blood gas analysis;Blood biochemical index;Acute exacerbation of chronic obstructive pulmonary disease;Complications;—

Countries

China

Contacts

Public ContactHu Guoping

The Third Affiliated Hospital of Guangzhou Medical University

hgpgz@126.com+86 13760661517

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026